SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) - ANVISA Registration 83056470003

Access comprehensive regulatory information for SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 83056470003 and manufactured by HANGZHOU ALLTEST BIOTECH CO. LTD. The registration is held by PRATI DONADUZZI & CIA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including HANGZHOU ALLTEST BIOTECH CO. LTD, ALAMAR TECNO CIENTÍFICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
83056470003
Registration Details
ANVISA Registration Number: 83056470003
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Prati Donaduzzi Diagnósticos Teste Rápido de Gravidez em Tira
Risk Class II

Registration Details

83056470003

25351114703202521

73856593000166

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Sep 01, 2025

VIGENTE

09/18/2025 19:00:01